EP3452500A4 - Prolifération de cellules souches mésenchymateuses - Google Patents

Prolifération de cellules souches mésenchymateuses Download PDF

Info

Publication number
EP3452500A4
EP3452500A4 EP17793552.5A EP17793552A EP3452500A4 EP 3452500 A4 EP3452500 A4 EP 3452500A4 EP 17793552 A EP17793552 A EP 17793552A EP 3452500 A4 EP3452500 A4 EP 3452500A4
Authority
EP
European Patent Office
Prior art keywords
stem cell
cell proliferation
mesenchymal stem
mesenchymal
proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17793552.5A
Other languages
German (de)
English (en)
Other versions
EP3452500A1 (fr
Inventor
Melinda SIMON
István HORNYÁK
Zsombor Lacza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lacerta Technologies Inc
Original Assignee
Lacerta Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacerta Technologies Inc filed Critical Lacerta Technologies Inc
Publication of EP3452500A1 publication Critical patent/EP3452500A1/fr
Publication of EP3452500A4 publication Critical patent/EP3452500A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/115—Platelets, megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
EP17793552.5A 2016-05-06 2017-05-08 Prolifération de cellules souches mésenchymateuses Pending EP3452500A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP1600306 2016-05-06
PCT/US2017/031585 WO2017193134A1 (fr) 2016-05-06 2017-05-08 Prolifération de cellules souches mésenchymateuses

Publications (2)

Publication Number Publication Date
EP3452500A1 EP3452500A1 (fr) 2019-03-13
EP3452500A4 true EP3452500A4 (fr) 2019-12-11

Family

ID=89720150

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17793552.5A Pending EP3452500A4 (fr) 2016-05-06 2017-05-08 Prolifération de cellules souches mésenchymateuses

Country Status (2)

Country Link
EP (1) EP3452500A4 (fr)
WO (1) WO2017193134A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943471A (zh) * 2017-12-21 2019-06-28 北京中原合聚经贸有限公司 一种间充质干细胞过滤灌流培养制备装置
CN110585243A (zh) * 2019-08-12 2019-12-20 丰泽康生物医药（深圳）有限公司 用于治疗糖皮质激素依赖性皮炎的多潜能细胞活性物与富血小板血浆复合物及制法和应用
WO2022180193A1 (fr) * 2021-02-25 2022-09-01 Swedish Stromabio Ab Compositions et procédés de prolifération de cellules stromales mésenchymateuses
CN113249332A (zh) * 2021-07-15 2021-08-13 北京大学第三医院（北京大学第三临床医学院） 一种alpl基因缺失骨髓间充质干细胞的建立方法
CN114869912A (zh) * 2022-05-23 2022-08-09 西安中美弘康生物科技有限公司 一种人间充质干细胞复合nPRF制剂的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090010896A1 (en) * 2007-07-05 2009-01-08 Centeno Christopher J Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2956150T3 (da) * 2013-02-12 2021-11-01 Lacerta Tech Inc Serumfraktion af trombocyt-rig fibrin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090010896A1 (en) * 2007-07-05 2009-01-08 Centeno Christopher J Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHI-SHENG CHIEN ET AL: "Incorporation of exudates of human platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilage", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B: APPLIED BIOMATERIALS, vol. 100B, no. 4, 25 May 2012 (2012-05-25), pages 948 - 955, XP055111158, ISSN: 1552-4973, DOI: 10.1002/jbm.b.32657 *
See also references of WO2017193134A1 *
SU C Y ET AL: "In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF", ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, ORAL RADIOLOGY AND ENDODONTICS, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, vol. 108, no. 1, 1 July 2009 (2009-07-01), pages 56 - 61, XP026434162, ISSN: 1079-2104, [retrieved on 20090517] *
THIERRY BURNOUF ET AL: "Human blood-derived fibrin releasates: Composition and use for the culture of cell lines and human primary cells", BIOLOGICALS, vol. 40, no. 1, 1 January 2012 (2012-01-01), pages 21 - 30, XP055111162, ISSN: 1045-1056, DOI: 10.1016/j.biologicals.2011.09.017 *

Also Published As

Publication number Publication date
EP3452500A1 (fr) 2019-03-13
WO2017193134A1 (fr) 2017-11-09

Similar Documents

Publication Publication Date Title
IL267616A (en) Immunologically engineered pluripotent cells
EP3345990A4 (fr) Système de production de cellules souches pluripotentes
EP3338487A4 (fr) Désambiguïsation d'identifiant de cellule
EP3217064A4 (fr) Station d'hydrogène
EP3333254A4 (fr) Exosome dérivé d'une cellule souche mésenchymateuse
EP3394250A4 (fr) Reprogrammation cellulaire
EP3612568B8 (fr) Cellule
EP3151873A4 (fr) Biomatériaux de verre de borate
EP3429360A4 (fr) Cellules souches mésenchymateuses présentant une efficacité améliorée
EP3455344A4 (fr) Cellules souches/progénitrices hématopoïétiques
GB201611982D0 (en) Cell culture
EP3702445B8 (fr) Nouvelle cellule souche musculo-squelettique
EP3561043A4 (fr) Substrat de culture cellulaire
EP3541924A4 (fr) Dosage de cellules souches pluripotentes
EP3142497A4 (fr) Composition contenant de l'hydrogène
EP3504315A4 (fr) Bioréacteur
EP3452500A4 (fr) Prolifération de cellules souches mésenchymateuses
EP3383182A4 (fr) Procédés de production de cellules souches hématopoïétiques fonctionnelles
EP3299023A4 (fr) Cellule souche mésenchymateuse cultivée en hypoxie et utilisation de celle-ci
EP3146978A4 (fr) Inhibiteur de prolifération de cellule souche cancéreuse
EP3365107B8 (fr) Culture cellulaire
EP3419617A4 (fr) Cellules souches hématopoïétiques à haut potentiel de prise de greffe
EP3464565A4 (fr) Expansion cellulaire
GB201701509D0 (en) Pluripotenet stem cells
EP3448986A4 (fr) Culture de cellules

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SIMON, MELINDA

Inventor name: LACZA, ZSOMBOR

Inventor name: HORNYAK, ISTVAN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20191113

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 27/36 20060101ALI20191107BHEP

Ipc: A61K 38/18 20060101ALI20191107BHEP

Ipc: A61K 35/28 20150101ALI20191107BHEP

Ipc: A61P 19/00 20060101ALI20191107BHEP

Ipc: C07K 14/75 20060101AFI20191107BHEP

Ipc: C12N 5/0775 20100101ALI20191107BHEP

Ipc: A61K 38/36 20060101ALI20191107BHEP

Ipc: A61L 27/54 20060101ALI20191107BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210503

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS